NVUS

Novus Therapeutics (NVUS)

Novus Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:NVUS

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2023/06/22	19:02	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:NVUS	Novus Therapeutics Inc
2023/06/09	05:05	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NASDAQ:NVUS	Novus Therapeutics Inc
2023/06/05	19:04	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:NVUS	Novus Therapeutics Inc
2023/05/23	02:27	Edgar (US Regulatory)	Small Company Offering and Sale of Securities Without Registration (d)	NASDAQ:NVUS	Novus Therapeutics Inc
2023/05/19	06:16	Edgar (US Regulatory)	Securities Registration Statement (simplified Form) (s-3)	NASDAQ:NVUS	Novus Therapeutics Inc
2023/05/12	06:07	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:NVUS	Novus Therapeutics Inc
2023/05/12	05:04	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:NVUS	Novus Therapeutics Inc
2023/05/03	07:49	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:NVUS	Novus Therapeutics Inc
2023/05/03	07:49	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:NVUS	Novus Therapeutics Inc
2023/05/03	07:48	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:NVUS	Novus Therapeutics Inc
2023/05/03	07:46	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:NVUS	Novus Therapeutics Inc
2023/05/03	07:44	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:NVUS	Novus Therapeutics Inc
2023/05/03	07:43	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:NVUS	Novus Therapeutics Inc
2023/05/02	05:53	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:NVUS	Novus Therapeutics Inc
2023/05/02	05:49	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:NVUS	Novus Therapeutics Inc
2023/05/01	20:28	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:NVUS	Novus Therapeutics Inc
2023/03/31	05:05	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:NVUS	Novus Therapeutics Inc
2023/02/03	08:12	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:NVUS	Novus Therapeutics Inc
2023/02/03	08:10	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:NVUS	Novus Therapeutics Inc
2023/02/03	08:09	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:NVUS	Novus Therapeutics Inc
2023/02/03	08:08	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:NVUS	Novus Therapeutics Inc
2023/02/03	08:05	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:NVUS	Novus Therapeutics Inc
2023/02/03	07:59	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:NVUS	Novus Therapeutics Inc
2023/02/03	07:45	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:NVUS	Novus Therapeutics Inc
2023/02/03	07:41	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:NVUS	Novus Therapeutics Inc
2022/11/24	06:07	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:NVUS	Novus Therapeutics Inc
2022/11/15	07:41	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:NVUS	Novus Therapeutics Inc
2022/11/15	06:09	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:NVUS	Novus Therapeutics Inc
2022/08/12	06:03	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:NVUS	Novus Therapeutics Inc
2022/08/12	05:08	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:NVUS	Novus Therapeutics Inc